Frank Torti Immunovant, Inc. (IMVT) insider trading activity

IMVT Quotes by TradingView

Frank Torti is Director of Immunovant, Inc.. Currently has a direct ownership of 835,039 shares of IMVT, which is worth approximately $23 Million. The most recent transaction as insider was on Apr 01, 2025, when has been sold 199,365 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 835K
31.36% 3M change
31.36% 12M change
Total Value Held $23 Million

Frank Torti Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2025
BUY
Grant, award, or other acquisition
-
199,365 Added 19.27%
835,039 Common Stock
Apr 02 2024
BUY
Grant, award, or other acquisition
-
120,400 Added 15.92%
635,674 Common Stock
Apr 12 2023
BUY
Grant, award, or other acquisition
-
121,916 Added 19.13%
515,274 Common Stock
Sep 29 2022
BUY
Open market or private purchase
$116,200 $5.81 p/Share
20,000 Added 4.84%
393,358 Common Stock
Aug 17 2022
BUY
Grant, award, or other acquisition
-
225,632 Added 37.67%
373,358 Common Stock
Jan 10 2022
BUY
Grant, award, or other acquisition
-
100,126 Added 40.4%
147,726 Common Stock
Mar 19 2021
BUY
Grant, award, or other acquisition
-
19,200 Added 28.74%
47,600 Common Stock

Also insider at

SIOX
Sio Gene Therapies Inc. Healthcare
Director
ABUS
Arbutus Biopharma Corp Healthcare
Director
FT

Frank Torti

Director
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMVT